| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |